Cardiovascular Events, Malignancies, and Efficacy Outcomes in Latin American Patients With Rheumatoid Arthritis Receiving Tofacitinib or Tumor Necrosis Factor Inhibitors: A Post Hoc Analysis of the ORAL Surveillance Study.
Gustavo CiteraEduardo MyslerAdriana Maria KakehasiVirginia Pascual-RamosWalter MassonMary Jane CadatalJose L RivasFarzad SheibanieClaudia HellingDario Ponce de LeonPublished in: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases (2024)
NCT02092467.